Effect of N-acetyl Cysteine(NAC) & Metformin co-treatment in patients with PCOs and undergoing ICSI treatment
Not Applicable
- Conditions
- polycystic ovarian syndrome.E28.2
- Registration Number
- IRCT201204159476N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Inclusion critria: age between 25 to 35 years old and PCOS diagnosed according to Rotterdam criteria (2003).
Exclusion criteria: presence of infertility factors other than anovulation,male infertility; pelvic organic pathologies; congenital adrenal hyperplasia; thyroid dysfunction; Cushing’s syndrome; hyperprolactinemia; androgen secreting neoplasia; diabetes mellitus; severe hepatic or kidney diseases and active peptic ulcer.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biochemical factors of follicular fluid. Timepoint: After 2 month. Method of measurement: Lab. kits.;Oocyte and embryo quality. Timepoint: After 2 month. Method of measurement: Morphology.;Biochemical factors of blood serum. Timepoint: After 2 month. Method of measurement: Lab. kits.
- Secondary Outcome Measures
Name Time Method Gastation rate. Timepoint: After 3 month. Method of measurement: Lab. kit.